Ashland Global
ASH NYSE· Diversified Chemicals
Last close · Oct 27, 2026
$72.78
KIRA · Stoqly’s AI analyst, in plain words
- Ashland Global had $1.8B of revenue in fiscal 2025, down 13.7% on the year before. Over five years, revenue changed −2.0% a year on average.
- Its operating margin was −42.5%, down 41.3 pts: of every 100 in sales, about −42 is left after running the business.
- Ashland Global lost $845M in fiscal 2025.
- Free cash flow was $36.0M in fiscal 2025, 2.0% of revenue.
- Ashland Global returned $176M to shareholders in fiscal 2025, 489% of free cash flow. The diluted share count fell 8.0%.
- Ashland Global owes $1.2B more than it holds in cash.
Market cap
$3.3B
P/E
69.3x
Revenue
$1.8B
Net income
−$845M
Free cash flow
$36.0M
Operating margin
−42.5%
Ashland Global in 30 seconds · fiscal 2025
Are sales growing?
−13.7%
No. Sales fell 13.7% last year.
Does it make a profit?
−46.3%
No. It lost money last year.
Does profit turn into cash?
2.0%
Partly. 2.0% of sales ends up as free cash.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
69.3x
One share costs 69.3 times its yearly profit per share. Typical for its sector: 20.1x.
What Ashland Global does
No business description yet.
- Fiscal year ends
- September 30, 2025
- Latest annual report
- 10-K · Nov 20, 2025
- Legal name
- ASHLAND INC.
- CIK
- 0001674862
Ashland Global · ASH
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $2.1B | $2.4B | $2.2B | $2.1B | $1.8B |
| Revenue growth | 4.7% | 13.3% | −8.4% | −3.6% | −13.7% |
| Gross margin | 31.7% | 34.7% | 30.5% | 29.3% | 30.1% |
| Operating margin | 9.1% | 13.9% | 7.9% | −1.2% | −42.5% |
| Net income | $220M | $927M | $178M | $169M | −$845M |
| Net margin | 10.4% | 38.8% | 8.1% | 8.0% | −46.3% |
| Diluted EPS | $3.59 | $16.41 | $3.31 | $3.36 | −$18.23 |
| Cash | |||||
| Cash from operations | $466M | $193M | $294M | $462M | $134M |
| Capital expenditure | $105M | $113M | $170M | $137M | $98.0M |
| Free cash flow | $361M | $80.0M | $124M | $325M | $36.0M |
| FCF margin | 17.1% | 3.4% | 5.7% | 15.4% | 2.0% |
| Dividends paid | $70.0M | $70.0M | $76.0M | $78.0M | $76.0M |
| Share buybacks | $450M | $200M | $300M | $380M | $100M |
| Share count change | 0.0% | −8.2% | −3.6% | −7.4% | −8.0% |
| Debt and strength | |||||
| Cash and short-term investments | $210M | $646M | $417M | $300M | $215M |
| Debt incl. finance leases | $2.0B | $1.3B | $1.3B | $1.3B | $1.4B |
| Shareholders' equity | $2.8B | $3.2B | $3.1B | $2.9B | $1.9B |
| Net debt / EBITDA | 4.0x | 1.1x | 2.2x | 4.2x | — |
| Current ratio | 1.8x | 3.2x | 3.3x | 2.4x | 2.9x |
| Interest coverage | 2.8x | 5.4x | 3.2x | −0.5x | −12.7x |
| Returns and quality | |||||
| Return on capital | 4.3% | 7.0% | 4.4% | −0.5% | −17.5% |
| Return on equity | 7.6% | 31.0% | 5.6% | 5.7% | −35.4% |
| Piotroski F-score | 7 | 8 | 5 | 5 | 5 |
| Altman Z'' | 3.1 | 4.7 | 4.5 | 3.8 | 2.4 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Ashland Global · ASH
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Ashland Global ASH | $3.3B | −13.7% | −42.5% | 2.0% | −17.5% | 69.3x | 5 |
| Cabot CBT | $3.9B | −7.0% | 16.7% | 10.5% | 15.9% | 12.9x | 6 |
| Chemours CC | $2.0B | 0.5% | — | 0.9% | −0.2% | — | 4 |
| Olin OLN | $1.9B | 3.7% | 0.1% | 3.7% | 0.1% | — | 4 |
| Materion MTRN | $5.0B | 6.0% | 6.2% | 2.8% | 7.3% | 54.9x | 7 |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $72.78 a share, the company is worth $3.3B: 69.3 times its earnings of the last four quarters.
Ashland Global grew sales faster than 0 of its 4 similar companies. Its P/E is higher than 2 of 2.
Source: SEC EDGAR XBRL filings (CIK 0001674862). Data updated October 9, 2026. For information only — not investment advice. Check the original filings before relying on any figure.